These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8153666)

  • 21. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T; Yamamoto M; Oshiro S; Tsugu H; Hirakawa K; Soma G
    Anticancer Res; 2003; 23(6a):4473-81. PubMed ID: 14666736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Individualized therapy and outcomes of microsurgery, radiotherapy, and chemotherapy for astrocytoma].
    Zhou WN; Chen ZP; You C; Mu YG; Sai K; Zhang JY; Zhang XH; Cheng JJ; Xu HC
    Ai Zheng; 2004 Nov; 23(11 Suppl):1555-60. PubMed ID: 15566679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug delivery to brain tumours: challenges and progress.
    Ningaraj NS
    Expert Opin Drug Deliv; 2006 Jul; 3(4):499-509. PubMed ID: 16822225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of carmustine, cisplatin, and oral etoposide chemotherapy before radiotherapy for grade 3 astrocytoma (anaplastic astrocytoma): results of North Central Cancer Treatment Group trial 98-72-51.
    Rao RD; Krishnan S; Fitch TR; Schomberg PJ; Dinapoli RP; Nordstrom K; Scheithauer B; O'Fallon JR; Maurer MJ; Buckner JC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):380-6. PubMed ID: 15667956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain tumors: controversies and challenges in management.
    Lesniak MS
    Expert Rev Neurother; 2005 Nov; 5(6 Suppl):1-2. PubMed ID: 16274264
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxicity profile of delayed high dose sodium thiosulfate in children treated with carboplatin in conjunction with blood-brain-barrier disruption.
    Neuwelt EA; Gilmer-Knight K; Lacy C; Nicholson HS; Kraemer DF; Doolittle ND; Hornig GW; Muldoon LL
    Pediatr Blood Cancer; 2006 Aug; 47(2):174-82. PubMed ID: 16086410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I-II diaziquone chemotherapy in brain tumors.
    Madajewicz S; Spaulding M; Bhimani S; Avellanosa A; DeLos Santos R; Perry A; Zeigler P; Kirshner J
    Cancer Treat Rep; 1984 Jun; 68(6):913-4. PubMed ID: 6733706
    [No Abstract]   [Full Text] [Related]  

  • 28. Radiochemotherapy of malignant glioma in adults. Clinical experiences.
    Kortmann RD; Jeremic B; Weller M; Plasswilm L; Bamberg M
    Strahlenther Onkol; 2003 Apr; 179(4):219-32. PubMed ID: 12707711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood-brain barrier and chemotherapeutic treatment of brain tumors.
    de Vries NA; Beijnen JH; Boogerd W; van Tellingen O
    Expert Rev Neurother; 2006 Aug; 6(8):1199-209. PubMed ID: 16893347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDA approves first drug formulated for children with rare brain tumor.
    Home Healthc Nurse; 2013 Feb; 31(2):56-7. PubMed ID: 23520605
    [No Abstract]   [Full Text] [Related]  

  • 31. Successful combination chemotherapy (vincristine, procarbazine, etoposide, and prednisolone) in the treatment of inoperable, radioresistant low grade astrocytoma: a case report.
    Maipang MVasiknanonte P; Janjindamai SHirunpat S
    J Med Assoc Thai; 2000 Dec; 83(12):1525-9. PubMed ID: 11253894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCNU-DBD (Dibromodulcitol) chemotherapy of recurrent supratentorial anaplastic astrocytomas and glioblastomas.
    Vitanovics D; Sipos L; Afra D
    Neoplasma; 2002; 49(5):342-5. PubMed ID: 12458335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ukrain therapy in a frontal anaplastic grade III astrocytoma (case report).
    Steinacker J; Kroiss T; Korsh OB; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):275-7. PubMed ID: 8899347
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An appraisal of chemotherapy: in the blood or in the brain?
    Schmidt MH; Chang SM; Berger MS
    Clin Neurosurg; 2001; 48():46-59. PubMed ID: 11692656
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose thiotepa and etoposide in children with poor-prognosis brain tumors.
    Fagioli F; Biasin E; Mastrodicasa L; Sandri A; Ferrero I; Berger M; Vassallo E; Madon E
    Cancer; 2004 May; 100(10):2215-21. PubMed ID: 15139067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Neurologic oncotherapy using blood-brain-barrier disruption].
    Heimberger K; Deecke L
    Dtsch Med Wochenschr; 1986 Nov; 111(47):1822. PubMed ID: 3780452
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination chemotherapy for the 9L rat brain tumor model system.
    Vats TS; Kimler BF; Henderson SD; Morantz RA
    Cancer Treat Rep; 1982 Mar; 66(3):575-9. PubMed ID: 6174232
    [No Abstract]   [Full Text] [Related]  

  • 38. Platinum analogues in the treatment of recurrent high grade astrocytoma.
    Huncharek M; Kupelnick B; Bishop D
    Cancer Treat Rev; 1998 Oct; 24(5):307-16. PubMed ID: 9861194
    [No Abstract]   [Full Text] [Related]  

  • 39. Imaging and drug delivery to tumor-infiltrated brain.
    Black KL
    Clin Neurosurg; 1994; 41():563-72. PubMed ID: 7842624
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin and astrocytomas.
    Rutka JT
    J Neurosurg; 2007 Feb; 106(2):337; discussion 337. PubMed ID: 17410720
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.